Affiliated Treatment Facilities
Duchossois Center for Advanced Medicine - Hyde Park
5758 South Maryland Avenue
Chicago, IL 60637
01. Doctor Overview
Doctor Overview
Dr. Mecker Möller is an abdominal cancer surgeon at the University of Chicago in Chicago, Illinois. She specializes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). This type of chemotherapy can treat peritoneal mesothelioma. She previously led the HIPEC program at the Sylvester Comprehensive Cancer Center. She is fluent in English and Spanish.
Dr. Möller is also an impassioned advocate. On the patient side, she shines a light on the need for better cancer care for all, including low-income people, racial and ethnic minorities and those in rural areas. On the professional side, she strives for gender parity in the field of oncology. She does this by challenging biases against women and fighting for more family-friendly policies.
02. Fast Facts
Doctor Fast Facts
Main Specialty: Surgical Oncology
Other Interests & Specialties: Gastrointestinal surgery (GI surgery), appendix cancer, cancer surgery, colorectal cancer, HIPEC, melanoma, mesothelioma, regional cancer therapy, sarcomas and stomach cancer.
Certifications, Awards & Accolades: Academy of Master Surgeons Educators of the American College of Surgeons, Latino Surgical Society and Association of Women Surgeons Visiting Professorship Award
Education & Experience:
- Medical Degree from Universidad Nacional Autónoma de Nicaragua-Leon
- Internship at Grand Rapids Medical Education & Research Center and Michigan State University
- Fellowship in Surgical Oncology at Moffitt Cancer Center
- Residency in Surgery at Michigan State University
03. Publications
Publications
When benchmarks fail us: a case study in cytoreductive surgery. Ann Surg Oncol. 2024 Oct 26.
Hyperthermic intraperitoneal chemotherapy in colorectal cancer. BJS Open. 2024 May 8;8(3):zrae017.
The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer. 2020 Jun 1;126(11):2547–52.
The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014 Dec;110(7):779–85.